European Equities Traded in the US as American Depositary Receipts Edge Lower in Tuesday Trading

MT Newswires Live00:10

European equities traded in the US as American depositary receipts were trending lower late Tuesday morning, declining 0.17% to 1,828.18 on the S&P Europe Select ADR Index.

From continental Europe, the gainers were led by biotech firm Evaxion (EVAX) and biopharmaceutical company DBV Technologies (DBVT), which climbed 7.1% and 5.2% respectively. They were followed by biopharmaceutical company argenx (ARGX) and lender ING (ING), which advanced 2% and 1.6% respectively.

The decliners from continental Europe were led by internet browser company Opera (OPRA) and software firm SAP (SAP), which dropped 7.3% and 4.2% respectively. They were followed by biopharmaceutical company Cellectis (CLLS) and 3D printer company Materialise (MTLS), which lost 2.3% and 1.8% respectively.

From the UK and Ireland, the gainers were led by mining company BHP Group (BHP) and biopharmaceutical company Mereo BioPharma Group (MREO), which rose 4.8% and 4.1% respectively. They were followed by biotech firm Autolus Therapeutics (AUTL) and telecommunications operator Vodafone Group (VOD), which were up 2.5% and 1.6% respectively.

The decliners from the UK and Ireland were led by communications company WPP (WPP) and software firm Endava (DAVA), which fell 10% and 8.7% respectively. They were followed by education company Pearson (PSO) and biopharmaceutical company Bicycle Therapeutics (BCYC), which were down 7.6% and 7.1% respectively.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment